Similar articles

Abstract: This study aims to elucidate the antiproliferative mechanism of hydroxychavicol (HC). Its effects on cell cycle, apoptosis, and the expression of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) in HT-29 colon cancer cells were investigated. HC was isolated from Piper betle leaf (PBL) and verified by high-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR), and gas chromatography-mass spectrometry (GC-MS). The cytotoxic effects of the standard drug 5-fluorouracil (5-FU), PBL water extract, and HC on HT-29 cells were measured after 24, 48, and 72 h of treatment. cell cycle and apoptosis modulation by 5-FU and HC treatments were investigated up to 30 h. Changes in phosphorylated JNK (pJNK) and P38 (pP38) MAPK expression were observed up to 18 h. The half maximal inhibitory concentration (IC₅₀) values of HC (30 μg/mL) and PBL water extract (380 μg/mL) were achieved at 24 h, whereas the IC₅₀ of 5-FU (50 μmol/L) was obtained at 72 h. cell cycle arrest at the G₀/G₁ phase in HC-treated cells was observed from 12 h onwards. Higher apoptotic cell death in HC-treated cells compared to 5-FU-treated cells (P<0.05) was observed. High expression of pJNK and pP38 MAPK was observed at 12 h in HC-treated cells, but not in 5-FU-treated HT-29 cells (P<0.05). It is concluded that HC induces cell cycle arrest and apoptosis of HT-29 cells, with these actions possibly mediated by JNK and P38 MAPK.

从花椒叶中提取的羟基胡椒酚可以诱导耐TP53的HT-29结肠癌细胞的细胞周期阻滞和凋亡

[1]Abrahim NN, Kanthimathi MS, Abdul-Aziz A, 2012. Piper betle shows antioxidant activities, inhibits MCF-7 cell proliferation and increases activities of catalase and superoxide dismutase. BMC Complement Altern Med, 12:220.

[2]Amin A, Gali-Muhtasib H, Ocker M, et al., 2009. Overview of major classes of plant-derived anticancer drugs. Int J Biomed Sci, 5(1):1-11.

[3]Angulo P, Kaushik G, Subramaniam D, et al., 2017. Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy. J Hematol Oncol, 10:10.

[4]Batra P, Sharma AK, 2013. Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech, 3(6):439-459.

[5]Bhanot A, Sharma R, Noolvi MN, 2011. Natural sources as potential anti-cancer agents: a review. Int J Phytomed, 3(1):9-26.

[6]Bossi G, Lapi E, Strano S, et al., 2006. Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression. Oncogene, 25(2):304-309.

[7]Boyer J, McLean EG, Aroori S, et al., 2004. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan. Clin Cancer Res, 10(6):2158-2167.

[8]Brown CJ, Cheok CF, Verma CS, et al., 2011. Reactivation of p53: from peptides to small molecules. Trends Pharmacol Sci, 32(1):53-62.

[9]Chakraborty JB, Mahato SK, Joshi K, et al., 2012. Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species-dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance. Cancer Sci, 103(1):88-99.

[10]Chang MC, Uang BJ, Wu HL, et al., 2002. Inducing the cell cycle arrest and apoptosis of oral KB carcinoma cells by hydroxychavicol: roles of glutathione and reactive oxygen species. Br J Pharmacol, 135(3):619-630.

[11]Chang MC, Uang BJ, Tsai CY, et al., 2007. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization. Br J Pharmacol, 152(1):73-82.

[12]Chen CL, Chi CW, Liu TY, 2000. Enhanced hydroxychavicol-induced cytotoxic effects in glutathione-depleted HepG2 cells. Cancer Lett, 155(1):29-35.

[13]Chowdhury AA, Chaudhuri J, Biswas N, et al., 2013. Synergistic apoptosis of CML cells by buthionine sulfoximine and hydroxychavicol correlates with activation of aif and GSH-ROS-JNK-ERK-iNOS pathway. PLoS ONE, 8(9):e73672.

[14]Dhanasekaran DN, Reddy EP, 2008. JNK signaling in apoptosis. Oncogene, 27(48):6245-6251.

[15]Dhillon AS, Hagan S, Rath O, et al., 2007. MAP kinase signalling pathways in cancer. Oncogene, 26(22):3279-3290.

[16]Garodia P, Ichikawa H, Malani N, et al., 2007. From ancient medicine to modern medicine: ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integr Oncol, 5(1):25-37.

[17]Garufi A, Pistritto G, Cirone M, et al., 2016. Reactivation of mutant p53 by capsaicin, the major constituent of peppers. J Exp Clin Cancer Rese, 35:136.

[18]Gokare P, Finnberg NK, Abbosh PH, et al., 2017. P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting. Sci Rep, 7:9711.

[19]Gundala SR, Aneja R, 2014. Piper betle leaf: a reservoir of potential xenohormetic nutraceuticals with cancer-fighting properties. Cancer Prev Res, 7(5):477-486.

[20]Gundala SR, Yang CH, Mukkavilli R, et al., 2014. Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis. Toxicol Appl Pharmacol, 280(1):86-96.

[21]Hanahan D, Weinberg RA, 2011. Hallmarks of cancer: the next generation. Cell, 144(5):646-674.

[22]Jeng JH, Ho YS, Chan CP, et al., 2000. Areca nut extract up-regulates prostaglandin production, cyclooxygenase-2 mRNA and protein expression of human oral keratinocytes. Carcinogenesis, 21(7):1365-1370.

[23]Jeng JH, Chang MC, Hahn LJ, 2001. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol, 37(6):477-492.

[24]Jeng JH, Chen SY, Liao CH, et al., 2002. Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of reactive oxygen species and cyclooxygenase. Free Radic Biol Med, 32(9):860-871.

[25]Jeng JH, Wang YJ, Chang WH, et al., 2004. Reactive oxygen species are crucial for hydroxychavicol toxicity toward KB epithelial cells. Cell Mol Life Sci, 61(1):83-96.

[26]Kitagishi Y, Kobayashi M, Matsuda S, 2012. Protection against cancer with medicinal herbs via activation of tumor suppressor. J Oncol, 2012:236530.

[27]Kumar N, Misra P, Dube A, et al., 2010. Piper betle Linn. a maligned Pan-Asiatic plant with an array of pharmacological activities and prospects for drug discovery. Curr Sci, 99(7):922-932.

[28]Longley DB, Harkin DP, Johnston PG, 2003. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer, 3(5):330-338.

[29]Majumdar AG, Subramanian M, 2019. Hydroxychavicol from Piper betle induces apoptosis, cell cycle arrest, and inhibits epithelial-mesenchymal transition in pancreatic cancer cells. Biochem Pharmacol, 166:274-291.

[30]Martins CP, Brown-Swigart L, Evan GI, 2006. Modeling the therapeutic efficacy of p53 restoration in tumors. Cell, 127(7):1323-1334.

[31]Ng PL, Rajab NF, Then SM, et al., 2014. Piper betle leaf extract enhances the cytotoxicity effect of 5-fluorouracil in inhibiting the growth of HT29 and HCT116 colon cancer cells. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 15(8):692-700.

[32]Ozaki T, Nakagawara A, 2011. Role of p53 in cell death and human cancers. Cancers, 3(1):994-1013.

[33]Paranjpe R, Gundala SR, Lakshminarayana N, et al., 2013. Piper betel leaf extract: anticancer benefits and bio-guided fractionation to identify active principles for prostate cancer management. Carcinogenesis, 34(7):1558-1566.

[34]Rahman AA, Jamal ARA, Harun R, et al., 2014. Gamma-tocotrienol and hydroxy-chavicol synergistically inhibits growth and induces apoptosis of human glioma cells. BMC Complement Altern Med, 14:213.

[35]Sarkar FH, Li YW, Wang ZW, et al., 2009. Cellular signaling perturbation by natural products. Cell Signal, 21(11):1541-1547.

[36]Slattery ML, Lundgreen A, Wolff RK, 2012. MAP kinase genes and colon and rectal cancer. Carcinogenesis, 33(12): 2398-2408.

[37]Sui XB, Kong N, Wang X, et al., 2014. JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy. Sci Rep, 4:4694.

[38]Sung B, Prasad S, Yadav VR, et al., 2012. Cancer cell signaling pathways targeted by spice-derived nutraceuticals. Nutr Cancer, 64(2):173-197.

[39]Takayama T, Miyanishi K, Hayashi T, et al., 2006. Colorectal cancer: genetics of development and metastasis. J Gastroenterol, 41(3):185-192.

[40]Thornton TM, Rincon M, 2009. Non-classical p38 MAP kinase functions: cell cycle checkpoints and survival. Int J Biol Sci, 5(1):44-51.

[41]Trivedy CR, Craig G, Warnakulasuriya S, 2002. The oral health consequences of chewing areca nut. Addict Biol, 7(1):115-125.

[42]Wagner EF, Nebreda ÁR, 2009. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer, 9(8):537-549.

[43]Widowati W, Wijaya L, Wargasetia TL, et al., 2013. Antioxidant, anticancer, and apoptosis-inducing effects of Piper extracts in HeLa cells. J Exp Integr Med, 3(3):225-230.

[44]Wigmore PM, Mustafa S, El-Beltagy M, et al., 2010. Effects of 5-FU. In: Raffa RB, Tallarida RJ (Eds.), Chemo Fog: Cancer Chemotherapy-Related Cognitive Impairment. Springer, New York, p.157-164.

[45]Wiman KG, 2010. Pharmacological reactivation of mutant p53: from protein structure to the cancer patient. Oncogene, 29(30): 4245-4252.

[46]Zawacka-Pankau J, Selivanova G, 2015. Pharmacological reactivation of p53 as a strategy to treat cancer. J Intern Med, 277(2):248-259.

[47]Zhang N, Yin Y, Xu SJ, et al., 2008. 5-Fluorouracil: mechanisms of resistance and reversal strategies. Molecules, 13(8):1551-1569.